Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients

Abstract Objective The study aimed to investigate the effect of body composition changes during chemotherapy on clinical outcomes in patients with pancreatic cancer. Results In patients with locally advanced pancreatic cancer (LAPC), the cross-sectional area of skeletal muscle (SM) and adipose tissu...

Full description

Bibliographic Details
Main Authors: Dong Woo Shin, Minseok Albert Kim, Jong-chan Lee, Jaihwan Kim, Jin-Hyeok Hwang
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Research Notes
Subjects:
Online Access:https://doi.org/10.1186/s13104-021-05681-x